deflazacort
Sign in to saveAlso known as MDL 458, Calcort
Deflazacort, sold under the brand name Calcort among others, is a glucocorticoid belonging to acetonides or O-isopropylidene derivative. It is used as an anti-inflammatory and was patented in 1969 and approved for medical use in 1985. The US Food and Drug Administration considers it to be a first-in-class medication for Duchenne Muscular Dystrophy.
Key facts
- Drug.verifiedrevid
- 447631837
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.image
- Deflazacort structure.svg
- Drug.image_class
- skin-invert-image
- Drug.tradename
- Emflaza, Calcort, others
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
- H02
- Drug.ATC_suffix
- AB13
- Drug.legal_UK
- POM
- Drug.legal_US
- Rx-only
- Drug.protein_bound
- 40%
- Drug.metabolism
- By plasma esterases, to active metabolite
- Drug.elimination_half life
- 1.1–1.9 hours (metabolite)
- Drug.excretion
- Kidney (70%) and fecal (30%)
- Drug.CAS_number
- 14484-47-0
- Drug.PubChem
- 189821
- Drug.DrugBank
- DB11921
via Wikipedia infobox
Research
710 papers- Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy.Journal of neuromuscular diseases · 2022
- [Deflazacort-induced Steven-Johnson syndrome: a case report and literature review].Zhonghua er ke za zhi = Chinese journal of pediatrics · 2024
- Deflazacort.Journal of postgraduate medicine · 2009
- Deflazacort--an alternative to prednisolone?Drug and therapeutics bulletin · 1999
- Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids.BMC pharmacology & toxicology · 2017
via PubMed
Wikidata facts
- Mass
- 441.21513771199994
Show 6 more facts
- World Health Organisation international non-proprietary name
- deflazacort
- canonical SMILES
- CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C
- chemical formula
- C₂₅H₃₁NO₆
- isomeric SMILES
- CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)COC(=O)C
- Commons category
- Deflazacort
- defined daily dose
- 15
via Wikidata · CC0
~4 min read
Article
11 sectionsContents
- Medical uses
- Adverse effects
- Pharmacology
- Mechanism of action
- Relative potency
- History
- Society and culture
- Legal status
- Economics
- Brand names
- References
Deflazacort, sold under the brand name Calcort among others, is a glucocorticoid belonging to acetonides or O-isopropylidene derivative. It is used as an anti-inflammatory and was patented in 1969 and approved for medical use in 1985. The US Food and Drug Administration considers it to be a first-in-class medication for Duchenne Muscular Dystrophy.
== Medical uses == The manufacturer lists the following uses for deflazacort: